(Press-News.org) Embargoed for release until 5:00 p.m. ET on Monday 3 November 2025
Follow @Annalsofim on X, Facebook, Instagram, Bluesky, and Linkedin
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.
----------------------------
1. Semaglutide, tirzepatide, and dulaglutide have similar gastrointestinal safety profiles in clinical settings
Abstract: https://www.acpjournals.org/doi/10.7326/ANNALS-25-01724
URL goes live when the embargo lifts
A new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and tirzepatide in patients with type 2 diabetes (T2D). The study found that the medications have similar gastrointestinal safety profiles among those with T2D, providing clinicians with evidence to weigh the risks and benefits of these medications for their patients. The findings are published in Annals of Internal Medicine.
Prior placebo-controlled randomized controlled trials of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and tirzepatide have shown that these medications are associated with an increased risk for gastrointestinal-related adverse events; however, whether individual GLP-1 RAs and tirzepatide have different gastrointestinal safety among patients with type 2 diabetes in clinical practice remains unclear. Researchers from Brigham and Women's Hospital and Harvard Medical School and colleagues used data from Optum’s deidentified Clinformatics Data Mart database to emulate three clinic trials of adults with T2D initiating dulaglutide, subcutaneous semaglutide, or tirzepatide between 1 January 2019 and 30 August 2024. They assessed 65,238 matched pairs in the semaglutide versus dulaglutide cohort, 20,893 in the tirzepatide versus dulaglutide cohort, and 46,620 in the tirzepatide versus semaglutide cohort. The primary outcome was a composite of severe gastrointestinal AEs resulting in an inpatient and/or emergency department encounter. The hazard ratio of gastrointestinal events was 0.96 (95% CI, 0.87 to 1.06) in the semaglutide versus dulaglutide cohort, 0.96 (CI, 0.77 to 1.20) in the tirzepatide versus dulaglutide cohort, and 1.07 (CI, 0.90 to 1.26) in the tirzepatide versus semaglutide cohort. These findings were consistent across subgroups and sensitivity analyses. The results align with those seen in head-to-head randomized clinical trials and may help physicians when determining the benefits and risks of prescribing these popular medications.
Media contacts: For an embargoed PDF, please contact Gabby Macrina at gmacrina@acponline.org. To contact corresponding author Elisabetta Patorno, MD, DrPH, please email Meg Montgomery at mmontgomery3@mgb.org.
----------------------------
2. Review identifies most effective psychological therapies for perinatal depression
The findings will inform updated clinical practice guidelines on the treatment of perinatal depression
Abstract: https://www.acpjournals.org/doi/10.7326/ANNALS-24-03520
URL goes live when the embargo lifts
A systematic review and meta-analysis evaluated the effectiveness of psychological therapies for perinatal depression, the most prevalent maternal mental health disorder. The review found that cognitive behavioral therapy, behavioral activation, and interpersonal therapy may be more effective at treating perinatal depression than usual care. The results of the review will be used to inform the development of clinical practice guidelines related to the treatment of perinatal depression. The review is published in Annals of Internal Medicine.
Researchers commissioned by the Agency for Healthcare Research and Quality (AHRQ) and the American College of Obstetricians and Gynecologists (ACOG) analyzed 44 randomized controlled trials (RCTs) of psychological therapies for people with depression during pregnancy and up to one year postpartum published between January 2000 and March 2025. The primary outcomes were the effect of psychological treatments on depressive symptoms and recovery from depressive symptoms. The most studied interventions included cognitive behavioral therapy (CBT) and interpersonal therapy (IPT). The review found that CBT was probably more effective at reducing depression and anxiety symptoms than usual treatment, and there may have been higher rates of recovery with CBT versus usual treatment. Behavioral activation may be more effective at reducing depressive symptoms than usual treatment. Interpersonal therapy (IPT) was probably moderately effective in reducing depressive symptoms compared to usual treatment, and recovery rates may increase with IPT. Overall, CBT, behavioral activation, and IPT may be more effective overall for treating perinatal depression than usual care. However, the researchers note that studies included in the review primarily included White participants with higher educational attainment, so the results may not be applicable to a wider population of people.
Media contacts: For an embargoed PDF, please contact Gabby Macrina at gmacrina@acponline.org. To contact corresponding author Elyse Couch, PhD, please email Juan Siliezar at juan_siliezar@brown.edu.
----------------------------
3. Albumin-specific measurement more effective at determining kidney disease than total protein measurement
Abstract: https://www.acpjournals.org/doi/10.7326/ANNALS-25-02117
URL goes live when the embargo lifts
An individual patient-level meta-analysis assessed and compared the performance of urinary albumin–creatinine ratio (UACR) and urinary protein–creatinine ratio (UPCR) across chronic kidney disease (CKD)-related clinical outcomes. The analysis found that UACR was more strongly associated with development of kidney failure than UPCR, supporting the use of UACR as the preferred measure to stratify patients at risk for CKD-related outcomes. The findings are published in Annals of Internal Medicine.
Researchers from the Chronic Kidney Disease Prognosis Consortium (CKD-PC) studied data from 148,994 participants in cohorts of the CKD-PC who had UACR and UPCR measured on the same day. Cohorts are eligible to join the CKD-PC if they have sufficient data on kidney function and subsequent clinical outcomes. The researchers quantified the associations of UACR and UPCR with outcomes including incident kidney failure with kidney replacement therapy, myocardial infarction, stroke, heart failure, and cardiovascular death. The researchers found consistent associations for both UACR and UPCR for CKD-related adverse clinical outcomes. However, UACR was more strongly associated than UPCR with incident kidney failure. For patients with higher baseline UACR, lower estimated glomerular filtration rate (eGFR), diabetes, or glomerulonephritis, the comparative advantage of UACR was particularly strong. Associations with cardiovascular disease-related outcomes were similar for both UACR and UPCR, but subgroups with a higher baseline UACR saw somewhat stronger associations with UACR than with UPCR. The findings support the routine measurement of UACR to risk-stratify patients for CKD-related adverse outcomes.
Media contacts: For an embargoed PDF, please contact Gabby Macrina at gmacrina@acponline.org. To contact corresponding author Shoshana H. Ballew, PhD please email Gregory Williams at Gregory.Williams@nyulangone.org.
----------------------------
Also new this issue:
Artificial Intelligence–Assisted Data Extraction With a Large Language Model: A Study Within Reviews
Gerald Gartlehner, MD, MPH, et al.
Research and Reporting Methods
Abstract: https://www.acpjournals.org/doi/10.7326/ANNALS-25-00739
Overdue: Delayed Revision of Institutional Review Board Policies Characterizing Pregnant Women After the Revised Common Rule
Caleigh Propes, BA; and Stephanie R. Morain, PhD, MPH
Ideas and Opinions
Abstract: https://www.acpjournals.org/doi/10.7326/ANNALS-25-02499
Revaluing Physician Services: CMS Has Some (but not All) Answers
William Fox, MD
Ideas and Opinions
Abstract: https://www.acpjournals.org/doi/10.7326/ANNALS-25-03638
END
Semaglutide, tirzepatide, and dulaglutide have similar gastrointestinal safety profiles in clinical settings
2025-11-03
ELSE PRESS RELEASES FROM THIS DATE:
Neural implant smaller than salt grain wirelessly tracks brain
2025-11-03
ITHACA, N.Y. – Cornell University researchers and collaborators have developed a neural implant so small that it can rest on a grain of salt, yet it can wirelessly transmit brain activity data in a living animal for more than a year.
The breakthrough, detailed Nov. 3 in Nature Electronics, demonstrates that microelectronic systems can function at an unprecedentedly small scale, opening new possibilities for neural monitoring, bio-integrated sensing and other applications.
Development of the device, called a microscale optoelectronic tetherless electrode, or MOTE, was co-led ...
Large brains require warm bodies and big offspring
2025-11-03
Vertebrates have extremely different brain sizes: even with the same body size, brain size can vary a hundredfold. As a rule, mammals and birds have the largest brains in relation to their body size, followed by sharks and reptiles. Amphibians and most fish, on the other hand, have the smallest brains of all vertebrates.
Why is this the case? In some animal groups, species that live in groups have larger brains than solitary species. They have to cope with rapidly changing social situations and therefore need ...
Team’s biosensor technology may lead to breath test for lung cancer
2025-11-03
University of Texas at Dallas researchers have developed biosensor technology that when combined with artificial intelligence (AI) shows promise for detecting lung cancer through breath analysis.
The electrochemical biosensor identifies eight volatile organic compounds (VOCs) that are potential biomarkers for thoracic cancers, which include lung and esophageal cancers. AI then analyzes the biochemical characteristics of the compounds to determine whether they are a match to those linked to various thoracic cancers.
“We built a screening tool that could allow physicians to catch the disease ...
Remote patient monitoring boosts primary care revenue and care capacity
2025-11-03
Remote physiologic monitoring (RPM)—digital tools that track patients’ health data between visits—shows promise for improving chronic disease management and reshaping primary care delivery, according to a new study at Columbia University Mailman School of Public Health. While prior studies have examined how RPM affects patients who use the technology, this is the first study to quantify the impact of RPM on practices, including its effects on practice revenue, care delivery, and ...
Protein plays unexpected dual role in protecting brain from oxidative stress damage
2025-11-03
New research from Johns Hopkins Medicine shows that the enzyme biliverdin reductase A (BVRA) plays a direct protective role against oxidative stress in neurons, independent of its role producing the yellow pigment bilirubin.
In this study of genetically engineered mice, the scientists say BVRA protected brain cells from oxidative stress, an imbalance between oxidants and antioxidants that protect cells, by modulating another key protein, NRF2, which regulates the levels of protective proteins and antioxidants in cells. Oxidative stress is a hallmark of neurodegenerative diseases, including Alzheimer’s disease.
A report describing the research, funded by the ...
Fermentation waste used to make natural fabric
2025-11-03
UNIVERSITY PARK, Pa. — A fermentation byproduct might help to solve two major global challenges: world hunger and the environmental impact of fast fashion. The leftover yeast from brewing beer, wine or even to make some pharmaceuticals can be repurposed to produce high-performance fibers stronger than natural fibers with significantly less environmental impact, according to a new study led by researchers at Penn State and published today (Nov 3) in the Proceedings of the National Academy of Sciences.
The yeast biomass — ...
When speaking out feels risky
2025-11-03
In an era when social media blurs the line between public and private speech, how do people decide whether to speak their minds or stay silent?
A new study from researchers at Arizona State University and the University of Michigan, published in the Proceedings of the National Academy of Sciences, or PNAS, offers a groundbreaking look at the strategic trade-offs individuals make when facing the threat of punishment for dissent.
The work, co-authored by Professor Stephanie Forrest and Assistant Professor Joshua J. Daymude in the School of Computing and Augmented Intelligence, part of the ...
Scientists recreate cosmic “fireballs” to probe mystery of missing gamma rays
2025-11-03
An international team of scientists, led by the University of Oxford, has achieved a world-first by creating plasma "fireballs" using the Super Proton Synchrotron accelerator at CERN, Geneva, to study the stability of plasma jets emanating from blazars. The results, published today (3 November) in PNAS, could shed new light on a long-standing mystery about the Universe’s hidden magnetic fields and missing gamma rays.
Blazars are active galaxies powered by supermassive black holes that launch narrow, near-light-speed ...
Turning on an immune pathway in tumors could lead to their destruction
2025-11-03
CAMBRIDGE, MA -- By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers have found a way to force tumors to trigger their own destruction.
Activating this signaling pathway, known as the cGAS-STING pathway, worked even better when combined with existing immunotherapy drugs known as checkpoint blockade inhibitors, in a study of mice. That dual treatment was successfully able to control tumor growth.
The researchers turned on the cGAS-STING pathway in immune cells using messenger RNA delivered to cancer cells. This approach may avoid the side effects of delivering large doses of a STING activator, and takes ...
Tiles, leaves and cotton strips for measuring river health
2025-11-03
Rivers perform a vital role in environmental balance. Keeping them in good condition depends not only on water quality, but also on the life they host and the processes that take place within them: plant respiration, decomposition of organic matter, and transformation of nutrients, among others. “The good condition of a river means taking into account both the organisms that inhabit it and the way it functions,” explained Luz Boyero, an Ikerbasque Research Professor at the EHU. Human activity may alter this natural dynamic, so tools need to be available to enable its effects to be detected in a timely manner.
With the aim of standardising methods for assessing river ...